Clinical efficacy and safety of medicines procured through China’s national volume-based procurement policy: a systematic review of 81 studies

Lele Zhang, Youjie Zhang

Open source

DOI
10.3389/fpubh.2026.1820505
Published
2026-10-15
Container
Frontiers in Public Health
Publisher
Frontiers Media SA
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3389/fpubh.2026.1820505,
  title = {Clinical efficacy and safety of medicines procured through China’s national volume-based procurement policy: a systematic review of 81 studies},
  author = {Lele Zhang and Youjie Zhang},
  year = {2026},
  journal = {Frontiers in Public Health},
  doi = {10.3389/fpubh.2026.1820505},
  url = {https://doi.org/10.3389/fpubh.2026.1820505}
}

RIS

TY  - JOUR
TI  - Clinical efficacy and safety of medicines procured through China’s national volume-based procurement policy: a systematic review of 81 studies
AU  - Lele Zhang
AU  - Youjie Zhang
PY  - 2026
JO  - Frontiers in Public Health
DO  - 10.3389/fpubh.2026.1820505
UR  - https://doi.org/10.3389/fpubh.2026.1820505
ER  - 

APA

Zhang, L., & Zhang, Y. (2026). Clinical efficacy and safety of medicines procured through China’s national volume-based procurement policy: a systematic review of 81 studies. Frontiers in Public Health. https://doi.org/10.3389/fpubh.2026.1820505

Source records